Qingdao Jiulong Biopharmaceutical

Qingdao Jiulong Biopharmaceutical is a prominent Chinese pharmaceutical company specializing in the development and manufacture of heparin-based anticoagulants. Founded in 1994 and headquartered in Qingdao, the company has established a robust production chain for high-quality Heparin Sodium API and Low Molecular Weight Heparins (LMWH), including Enoxaparin, Dalteparin, and Nadroparin. Its facilities are designed to meet international GMP standards, supporting its role as a major exporter to global markets. The company's products are critical for treating cardiovascular conditions and preventing thromboembolic events. Qingdao Jiulong continues to focus on technological innovation in polysaccharide purification and depolymerization to maintain its competitive edge in the global heparin industry.